Next steps in unlocking the power of computational biology for I-O target identification and validation

Immuno-Oncology Insights 2021; 2(5), 241–245

10.18609/ioi.2021.032

Published: 18 August 2021
Interview


Ning Wang is a bioinformatics scientist at Arcus Biosciences, where he is responsible for drug discovery, target identification, and indication prioritization in multiple immune-oncology drug programs. Notably, Ning pioneered the 3D organoids based drug response prediction technology, which largely facilitated cancer model selection. During his PhD, he studied with Professor Alexander Hoffmann at UCLA, where he built up computational framework to identify synergy between key immune response signaling pathways in macrophage. Ning holds a PhD in Bioinformatics from UCLA.